Accelerated review of VPAG concludes without agreement
The ABPI can confirm that industry and government have been unable to reach an agreement on changes to a controversial medicines payment scheme which is undermining UK patient access to innovative…
Read the full articleYou might also wanna read
NHS Fast-tracks Life-changing Medicines in Landmark UK-US Access Overhaul
A new series of NHS pilot schemes could give patients access to innovative medicines months earlier while supporting investment in the UK's
105 essential medicines: Delays in price revisions triggers shortages
KARACHI: More than two years after Pakistan’s drug pricing regulators recommended price revisions for 105 hardship-category medicines, the f
Resident doctors in England accept pay deal and end strikes
Doctors have been locked in a three-year dispute with the government, resulting in several rounds of strikes.
Dr Reddy’s delays Semaglutide supplies after API quality issue
Dr Reddy’s said patient safety and global regulatory filings remain unaffected as it investigates the issue.
A dangerous deal. An interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the government concluded with the United States under Donald Trump last December
A dangerous dealAn interesting story is gaining momentum in Britain around the British healthcare system (NHS) and the drug deal that the go
UK Life Sciences Must Move From Innovation Pilots to National Adoption
The UK is not short of innovation. The challenge is building the national systems, funding routes and procurement models needed to turn prom
Comments
Sign in to join the conversation.
No comments yet. Be the first.